ClinicalTrials.gov
public full text
Public Domain
INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial
Randomized, blind controlled, Multicenter, spontaneous, prospective trial, roughly 20 enrolling centers in Italy, placebo and active drug supply given by GlaxoSmithKline (GSK).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions#1086765
- STEMI and Incretins Treatment#874909
- Canadian Anticoagulant Percutaneous Coronary Intervention Registry#1102475
- Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac Artery#904308
- Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome#832191
Record · ID 1111406
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive